These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma. Rosen MA; Schnall MD Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308 [TBL] [Abstract][Full Text] [Related]
4. Noninvasive imaging of atherosclerotic vessels by MRI for clinical assessment of the effectiveness of therapy. Corti R Pharmacol Ther; 2006 Apr; 110(1):57-70. PubMed ID: 16445985 [TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Padhani AR; Husband JE Clin Radiol; 2001 Aug; 56(8):607-20. PubMed ID: 11467863 [TBL] [Abstract][Full Text] [Related]
6. Characterization and molecular detection of atherothrombosis by magnetic resonance--potential tools for individual risk assessment and diagnostics. Ala-Korpela M; Sipola P; Kaski K Ann Med; 2006; 38(5):322-36. PubMed ID: 16938802 [TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance molecular imaging contrast agents and their application in atherosclerosis. Mulder WJ; Strijkers GJ; Vucic E; Cormode DP; Nicolay K; Fayad ZA Top Magn Reson Imaging; 2007 Oct; 18(5):409-17. PubMed ID: 18025995 [TBL] [Abstract][Full Text] [Related]
8. Accurate magnetic resonance imaging of atherosclerotic plaques: change future strategies for the diagnosis and therapy of atherosclerotic disease. Liu XS; Xu JR Med Hypotheses; 2007; 68(3):656-60. PubMed ID: 17014968 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes. Briley-Saebo KC; Mulder WJ; Mani V; Hyafil F; Amirbekian V; Aguinaldo JG; Fisher EA; Fayad ZA J Magn Reson Imaging; 2007 Sep; 26(3):460-79. PubMed ID: 17729343 [TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. Padhani AR J Magn Reson Imaging; 2002 Oct; 16(4):407-22. PubMed ID: 12353256 [TBL] [Abstract][Full Text] [Related]
11. The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment. Saam T; Hatsukami TS; Takaya N; Chu B; Underhill H; Kerwin WS; Cai J; Ferguson MS; Yuan C Radiology; 2007 Jul; 244(1):64-77. PubMed ID: 17581895 [TBL] [Abstract][Full Text] [Related]
12. Molecular imaging by cardiovascular MR. Cyrus T; Lanza GM; Wickline SA J Cardiovasc Magn Reson; 2007; 9(6):827-43. PubMed ID: 18066742 [TBL] [Abstract][Full Text] [Related]
13. A method for pharmacokinetic modelling of dynamic contrast enhanced MRI studies of rapidly enhancing lesions acquired in a clinical setting. Radjenovic A; Ridgway JP; Smith MA Phys Med Biol; 2006 May; 51(9):N187-97. PubMed ID: 16625029 [TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis. Atkin G; Taylor NJ; Daley FM; Stirling JJ; Richman P; Glynne-Jones R; d'Arcy JA; Collins DJ; Padhani AR Br J Surg; 2006 Aug; 93(8):992-1000. PubMed ID: 16673354 [TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast enhanced MRI in prostate cancer. Alonzi R; Padhani AR; Allen C Eur J Radiol; 2007 Sep; 63(3):335-50. PubMed ID: 17689907 [TBL] [Abstract][Full Text] [Related]
16. Three-dimensional dynamic contrast-enhanced MRI for the accurate, extensive quantification of microvascular permeability in atherosclerotic plaques. Calcagno C; Lobatto ME; Dyvorne H; Robson PM; Millon A; Senders ML; Lairez O; Ramachandran S; Coolen BF; Black A; Mulder WJ; Fayad ZA NMR Biomed; 2015 Oct; 28(10):1304-14. PubMed ID: 26332103 [TBL] [Abstract][Full Text] [Related]
17. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging. Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720 [TBL] [Abstract][Full Text] [Related]
18. The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis. Sala E; Rockall A; Rangarajan D; Kubik-Huch RA Eur J Radiol; 2010 Dec; 76(3):367-85. PubMed ID: 20810230 [TBL] [Abstract][Full Text] [Related]
19. Imaging of atherosclerosis: magnetic resonance imaging. Corti R; Fuster V Eur Heart J; 2011 Jul; 32(14):1709-19b. PubMed ID: 21508002 [TBL] [Abstract][Full Text] [Related]
20. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Winter PM; Morawski AM; Caruthers SD; Fuhrhop RW; Zhang H; Williams TA; Allen JS; Lacy EK; Robertson JD; Lanza GM; Wickline SA Circulation; 2003 Nov; 108(18):2270-4. PubMed ID: 14557370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]